Study reveals data supporting the development of new treatment strategies for critically ill patients.Doctors from University College London (UCL) have recently reported their findings of a pioneering expedition to examine the world’s first measurements of blood oxygen levels in climbers near the summit of Everest.
The research team used a RAPIDLab® 348 Blood Gas Analyser from Siemens’ blood gas portfolio। These are known for ease-of-use, superior data management and ability to meet needs of various testing volumes. The aim of the study was to investigate human adaptation to hypoxia and establish whether high altitude climbers have very low blood oxygen levels, which at sea-level would only be seen in patients close to death. The results were recently published in the New England Journal of Medicine (NEJM)*.
For more Details http://www.siemens.co.uk/diagnostics
No comments:
Post a Comment